DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Bioabsorbable Stents Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.
The global bioabsorbable stents market is expected to grow at the CAGR of 44.7% during 2016-2022 and is expected to reach around $2800 million by 2022.
There has been a rising number of angioplasty procedures due to rising cardiovascular diseases, driving the global bioabsorbable stents market. Slow adoption rate of bioabsorbable stents in heart-related diseases is one of the major problems being faced by the global market and it also acts as a restraint in the growth of the market.
Geographically, the bioabsorbable market is divided into North America, Europe, Asia Pacific and rest of the World. North America is dominating with the maximum market share of global bioabsorbable stents market due to rise in awareness about the bioabsorbable stents in the treatment of coronary ailments, rising prevalence of obesity, heart attacks and other cardiac diseases.
Dominance of major players in this region is also fueling the global bioabsorbable stents market. United States is contributing the largest market for bioabsorbable stents in the North American region, followed by Canada. In the European region, Italy, Germany and U.K. are having largest market share of global bioabsorbable stents market.
Rising awareness regarding obesity-related health issues and increasing health care expenditures are enhancing the global bioabsorbable stents market. During the forecast period, the Asia Pacific region has been expected to be high growth due to increase in public awareness related to various peripheral and coronary artery diseases in the region. The contributors such as India, China and Japan are expected to be the fastest-growing bioabsorbable stents markets in Asia Pacific.
- Abbott Laboratories
- Amaranth Medical Inc.
- Arterial Remodeling Technologies
- Arterius Limited
- Boston Scientific Corp.
- Elixir Medical Corporation
- Johnson & Johnson
- Kyoto Medical Planning Co. Ltd.
- Medtronic Inc
- Meril Life Sciences
- Sahajanand Medical Technology (Part of Sahajanand Group of Companies)
- Tepha Inc
- Xenogenics Corporation (A Subsidiary of Multicell Technologies Inc.)
- Stentys S.A.S.
Bioabsorbable Therapeutics, Inc.
Key Topics Covered:
2. Market Overview
3. Market Determinants
4. Market Segmentation
5. Geographical Analysis
6. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/qlmd3t/global
Related Topics: Biomaterials